Dark

NAOV
NanoVibronix, Inc. Common Stock
stock NASDAQ

At Close

May 16, 2025 3:59:30 PM EDT

1.23USD-13.986%(-0.20)788,045

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:29:02 AM EDT

1.43USD0.000%(0.00)48,064

After-hours

May 16, 2025 4:49:30 PM EDT

1.31USD+6.504%(+0.08)5,897

OverviewHistoricalExchangesShortsNews

Jan 24, 2022

08:34AM EST NanoVibronix Extends Reach Of UroShield And PainShield Through MTSG's International Network Benzinga

Jan 19, 2022

08:37AM EST NanoVibronix Reports Filed 3 US Patent Applications To Leverage Surface Acoustic Wave Technology Benzinga

08:30AM EST NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology Business Wire

Jan 13, 2022

08:30AM EST NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors Business Wire

Jan 7, 2022

01:02PM EST NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference Business Wire

Jan 6, 2022

08:45AM EST NanoVibronix Further Expands VA Distribution Network To Include SDVOSB Delta Medical, LLC Benzinga

Jan 5, 2022

08:34AM EST NanoVibronix Signs Agreement With Applied Medical Solutions For Sale And Distribution Of PainShield For Veterans Administration Facilities Benzinga

08:30AM EST NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities Business Wire

Dec 21, 2021

03:15PM EST NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe Benzinga

10:30AM EST NanoVibronix Adjourns Special Meeting of Stockholders GlobeNewswire Inc

08:07AM EST NanoVibronix Announces Agreement With Medina Healthcare For Distribution Of UroShield And PainShield In Europe RTTNews

08:02AM EST NanoVibronix Announces Agreement With Medina Healthcare Limited For Distribution Of UroShield And PainShield In European Market Expansion Benzinga

08:00AM EST NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield(r) and PainShield(r) in European Market Expansion Business Wire

Dec 8, 2021

08:30AM EST NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL GlobeNewswire Inc

Dec 7, 2021

08:45AM EST NanoVibronix Announces Interim Results In Real World Patient Study Of UroShield Benzinga

08:30AM EST NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive interim results from an independent, real world patient study of its UroShield at Southampton University Health Sciences. GlobeNewswire Inc

Dec 2, 2021

05:42AM EST NanoVibronix Announced Early Success in the Marketing of Painshield to Veteran's Administration Healthcare Providers Benzinga

05:30AM EST NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that sales of its Painshield device to the Veterans Administration (VA) has been accelerating. GlobeNewswire Inc

Nov 16, 2021

08:38AM EST NanoVibronix Q3 EPS $(0.26) Down From $(0.10) YoY, Sales $499.00K Up From $150.00K YoY Benzinga

08:37AM EST NanoVibronix Q3 Revenue Of $499,000, Increase Of 233% From Prior Year RTTNews

08:30AM EST NanoVibronix Reports Third Quarter 2021 Financial Results Business Wire

Oct 28, 2021

09:29AM EDT NanoVibronix CEO Brian Murphy Provides Business Update In Letter To Shareholders (Full Letter) Benzinga

09:28AM EDT NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update and letter to shareholders from its Chief Executive Officer, Brian Murphy: GlobeNewswire Inc

Oct 11, 2021

09:10AM EDT UPDATE: Dr. David Lemak, Lead Investigator Of Study Of NanoVibronix PainsShield, Says 'Patient outcomes were markedly improved with the use of PainShield and importantly, no patients returned with signs or symptoms of an exacerbation' Benzinga

09:07AM EDT NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced positive results from a randomized, double-blind study conducted at Birmingham Orthopedic and Sports Specialists in Birmingham, Alabama. GlobeNewswire Inc

Sep 29, 2021

10:15AM EDT NanoVibronix Enters Worker's Compensation Market Through Agreement With Orchid Medical Benzinga

10:14AM EDT NANOVIBRONIX ENTERS WORKERS COMPENSATION MARKET GlobeNewswire Inc

Sep 14, 2021

08:30AM EDT NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it is launching a new, transdermal gel containing Nano-Cannabidiol (CBD) for the treatment of joint pain and reducing inflammation. GlobeNewswire Inc

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

05:57AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.32 A.M. EDT). RTTNews

Aug 17, 2021

02:32PM EDT NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today Business Wire

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

05:52AM EDT The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.37 A.M. EDT). RTTNews

Aug 16, 2021

04:11PM EDT NanoVibronix Q2 EPS $(0.01) Up From $(0.20) YoY, Sales $318.00K Up From $269.00K YoY Benzinga

04:05PM EDT NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended June 30, 2021 and provided a business update. GlobeNewswire Inc

02:32PM EDT Mid-Afternoon Market Update: Dow Turns Positive; Sesen Bio Shares Plummet Benzinga

12:13PM EDT Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump Benzinga

10:22AM EDT Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August Benzinga

08:33AM EDT MusclePharm Reports Direct Store Delivery Distribution Partnership With New Age For State Of Colorado, No Terms Disclosed Benzinga

08:32AM EDT NanoVibronix Announces Plan To Expand Product Portfolio With Introduction Of Painshield Relief For Over-The-Counter Use And Plans For Future Product Launch Benzinga

08:30AM EDT NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH GlobeNewswire Inc

Aug 11, 2021

08:34AM EDT NanoVibronix Reports Receives Registration Approval For Painshield From Australia's Therapeutic Goods Admin. Benzinga

08:30AM EDT NanoVibronix, Inc.,(NASDAQ: NAOV), a Healthcare device company that produces the UroShield and PainShieldSurface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Therapeutic Goods Administration (TGA), The Australian Regulatory body for Therapeutic Devices, has granted approval for the Companys PainShield for use by patients in Australia. GlobeNewswire Inc

Aug 5, 2021

08:56AM EDT NanoVibronix Applies for CMS Reimbursement Code for UroShield and PainShield Plus Benzinga

08:52AM EDT NanoVibronix Applies for CMS Reimbursement Code for UroShield(r) and PainShield Plus(r) Business Wire

Jul 29, 2021

02:30PM EDT Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Tempur Sealy Shares Spike Higher Benzinga

12:10PM EDT Mid-Day Market Update: LendingClub Surges Following Strong Q2 Results; Atreca Shares Plummet Benzinga

09:00AM EDT NanoVibronix Receives Registration Approval For UroShield From TGA Australia Benzinga

Jul 28, 2021

09:48AM EDT NanoVibronix Shares Spike Higher Premarket; Up 35%; Company on Monday Announced it Shipped First Order of PainShield Plus Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

Jul 26, 2021

10:53AM EDT NanoVibronix Says Ships First Order Of PainShield Plus RTTNews

10:48AM EDT NanoVibronix Says Ships First Order Of PainShield Plus; Says Expects To Recognize First Revenues From Product In Q3 2021 Benzinga

10:47AM EDT NanoVibronix Ships First Order of PainShield Plus Business Wire

10:23AM EDT Mid-Morning Market Update: Markets Mostly Lower; Lockheed Martin Posts Mixed Q2 Results Benzinga

Jul 23, 2021

02:00PM EDT NanoVibronix Shares Halted on Volatility Benzinga

01:54PM EDT NanoVibronix Halted for Volatility Benzinga

01:02PM EDT NanoVibronix Gets Australian Therapeutic Goods Administration Approval For Co's UroShield system Benzinga

Jul 22, 2021

08:16AM EDT NanoVibronix Highlights Publication Of UroShield Study Results For UroShield In The Journal Of Medical & Surgical Urology Benzinga

08:15AM EDT NanoVibronix Announces Publication of Compelling Study Results for GlobeNewswire Inc

Jun 3, 2021

08:30AM EDT NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided an update on its business. GlobeNewswire Inc

Apr 27, 2021

11:18AM EDT NanoVibronix Says Adjourns Special Meeting of Stockholders Benzinga

11:17AM EDT NanoVibronix Adjourns Special Meeting of Stockholders GlobeNewswire Inc

Apr 26, 2021

09:03AM EDT NanoVibronix Announces Expanded CMS Reimbursement Approval For PainShield Benzinga

09:00AM EDT NanoVibronix Announces Expanded CMS Reimbursement Approval for GlobeNewswire Inc

Apr 19, 2021

09:55AM EDT NanoVibronix Announces Start Of Real World Patient Study Of UroShield RTTNews

Apr 14, 2021

12:57PM EDT NanoVibronix Adjourns Special Meeting of Stockholders GlobeNewswire Inc

Mar 2, 2021

08:49AM EST NanoVibronix Says Co's UroShield Join's PainShield On Federal Supply Scheduled, Expands Access To VA Market Benzinga

08:30AM EST NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market Business Wire

Feb 10, 2021

08:00AM EST NanoVibronix Reports Schedule Published by NICE for Review of UroShield(r) Device Business Wire

Feb 3, 2021

08:12AM EST NanoVibronix Regains Nasdaq Compliance RTTNews

Feb 2, 2021

05:03PM EST NanoVibronix Says Received Letter From Nasdaq Notifying Co That Co Regained Compliance With Nasdaq Listing Rule Benzinga

Jan 22, 2021

06:17AM EST NanoVibronix 8-K Shows Co. Entered Deal With Existing Creditors To Exercise Certain Outstanding Warrants To Buy Up To ~1.2M Shares At $1.165/Share Benzinga

Jan 19, 2021

08:45AM EST NanoVibronix Issues Letter To Shareholders Benzinga

Jan 5, 2021

04:03PM EST NanoVibronix 8-K Shows Nasdaq Confirmed Co. Compliance Benzinga

Dec 11, 2020

08:07AM EST Nanovibronix Amends, Expands Distribution Agreement For PainShield, PainShield Plus Benzinga

08:00AM EST NanoVibronix Amends and Expands Distribution Agreement for Its PainShield(r) and PainShield Plus(r) Business Wire

Dec 10, 2020

04:35PM EST NanoVibronix S-3 Shows Registration For 9.69M Common Stock Shelf Offering Benzinga

Dec 8, 2020

08:06AM EST NanoVibronix Announces UroShield, PainShield Meet New Zealand Medicines And Medical Devices Safety Authority Regulatory Requirements Benzinga

Dec 7, 2020

05:10PM EST NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market Business Wire

Dec 2, 2020

01:02PM EST NanoVibronix Prices ~8.57M Share Offering At $0.70/Share Benzinga

01:01PM EST NanoVibronix Announces $6.0 Million Private Placement Business Wire

08:01AM EST NanoVibronix Announces Positive Findings From An Independent Evaluation Of Its UroShield Device RTTNews

07:54AM EST Independent Study Finds Significant Benefits Provided by NanoVibronix's UroShield(r) Device Business Wire

Nov 16, 2020

06:12PM EST NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update Business Wire

Oct 16, 2020

08:33AM EDT NanoVibronix Expands Offerings With Introduction Of PainShield Plus Benzinga

Oct 8, 2020

09:07AM EDT NanoVibronix Receives Positive Nasdaq Listing Determination Benzinga

Sep 29, 2020

08:56AM EDT NanoVibronix Files For US Patent For PainShield For Delivery Of Cannabinoids For Alleviation Of Chronic &Acute Pain RTTNews

08:51AM EDT NanoVibronix Files U.S. Patent Application For PainShield For Delivery Of Cannabinoids For Alleviation Of Chronic And Acute Pain Benzinga

08:51AM EDT NanoVibronix Files U.S. Patent Application for PainShield(r) for Delivery of PR Newswire

Sep 23, 2020

05:54AM EDT NanoVibronix Increased Previously Announced Bought Deal to $1.8M Benzinga

Sep 22, 2020

08:37PM EDT NanoVibronix Increases Previously Announced Bought Deal to $1.8 Million PR Newswire

06:12PM EDT NanoVibronix Announces $1.5 Million Bought Deal Offering PR Newswire

02:31PM EDT Mid-Afternoon Market Update: Dow Rises 100 Points; AIM ImmunoTech Shares Climb Benzinga

12:11PM EDT Mid-Day Market Update: Nasdaq Gains 60 Points; Vaccinex Shares Slide Benzinga

10:38AM EDT Why NanoVibronix's Stock Is Trading Higher Today Benzinga

08:06AM EDT NanoVibronix UroShield Receives FDA Authorization For Entry Into US Benzinga

08:05AM EDT NanoVibronix UroShield Gets FDA Authorization For Entry Into The U.S. RTTNews

08:01AM EDT NanoVibronix UroShield(r) Receives U.S. Food and Drug Administration PR Newswire

Aug 27, 2020

03:43PM EDT NanoVibronix Announces Closing of $3.4 Million Bought Deal Offering and Partial PR Newswire

Aug 25, 2020

02:30PM EDT Mid-Afternoon Market Update: Crude Oil Rises 2%; Children's Place Shares Plunge On Wider-Than-Expected Q2 Loss Benzinga

12:00PM EDT Mid-Day Market Update: Dow Tumbles 170 Points; Viveve Medical Shares Spike Higher Benzinga

06:48AM EDT NanoVibronix shares are trading lower after the company announced a bought deal offering of 4.3 million shares at $0.75 per share. Benzinga

05:34AM EDT NanoVibronix Priced 4.3M Share Public Offering @$0.75/Share Benzinga

Aug 24, 2020

11:53PM EDT NanoVibronix Increases Bought Deal To $3.25 Mln RTTNews

10:59PM EDT NanoVibronix Increases Previously Announced Bought Deal to $3.25 Million PR Newswire

05:28PM EDT NanoVibronix Announces $2.5M Bought Deal Offering Benzinga

05:24PM EDT NanoVibronix Announces $2.5 Million Bought Deal Offering PR Newswire

Aug 14, 2020

08:26AM EDT The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal Benzinga

Aug 13, 2020

08:36AM EDT NanoVibronix Announces First Shipments Of New UroShield Devices Benzinga

08:32AM EDT NanoVibronix Ships First Orders Of The New UroShield Device To The UK RTTNews

08:31AM EDT NanoVibronix Announces First Shipments of new UroShield(tm) Devices PR Newswire

Jul 21, 2020

06:05AM EDT NanoVibronix Inc Files For Mixed Shelf Of Up To $50M Benzinga